6105-75-5,MFCD01714129
Catalog No.:AA00E9SG

6105-75-5 | 2-Methyl-1-morpholinopropan-2-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$104.00   $73.00
- +
1g
95%
in stock  
$154.00   $108.00
- +
5g
95%
in stock  
$583.00 $408.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00E9SG
Chemical Name:
2-Methyl-1-morpholinopropan-2-amine
CAS Number:
6105-75-5
Molecular Formula:
C8H18N2O
Molecular Weight:
158.2413
MDL Number:
MFCD01714129
SMILES:
CC(CN1CCOCC1)(N)C
Properties
Properties
 
BP:
227.6°C at 760 mmHg  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
119  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.4  

Downstream Synthesis Route
6105-75-5    121-60-8   
<i>N</i>-acetyl-sulfanilicacid-(morpholino-<i>tert</i>-butyl)-amide 

[1]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

[1]CLAPP[JournaloftheAmericanChemicalSociety,1948,vol.70,#1,p.184-186]

[1]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2017/17630,2017,A1Locationinpatent:Page/Pagecolumn33

[2]CurrentPatentAssignee:HAISCOPHARMACEUTICALGROUPCO.,LTD.-CN112480121,2021,ALocationinpatent:Paragraph1053;1057;1062-1066

[3]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

[4]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

[5]Johnson[JournaloftheAmericanChemicalSociety,1946,vol.68,p.13]

[6]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-WO2006/18182,2006,A1Locationinpatent:Page/Pagecolumn68CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-WO2006/18185,2006,A2Locationinpatent:Page/Pagecolumn68

[7]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2006/35903,2006,A1Locationinpatent:Page/Pagecolumn18

[8]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2004/176380,2004,A1Locationinpatent:Page/Pagecolumn13

6105-75-5   
{5-(4-fluorobenzyl)-3-1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl-1H-pyrazol-1-yl}aceticacid 
 
N-(1,1-dimethyl-2-morpholin-4-ylethyl)-2-{5-(4-fluorobenzyl)-3-1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl-1H-pyrazol-1-yl}acetamide 

[1]CurrentPatentAssignee:PFIZERINC-WO2008/4096,2008,A1Locationinpatent:Page/Pagecolumn84-85

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:6105-75-5 Molecular Formula|6105-75-5 MDL|6105-75-5 SMILES|6105-75-5 2-Methyl-1-morpholinopropan-2-amine
Catalog No.: AA00E9SG
6105-75-5,MFCD01714129
6105-75-5 | 2-Methyl-1-morpholinopropan-2-amine
Pack Size: 250mg
Purity: 95%
in stock
$104.00 $73.00
Pack Size: 1g
Purity: 95%
in stock
$154.00 $108.00
Pack Size: 5g
Purity: 95%
in stock
$583.00 $408.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00E9SG
Chemical Name: 2-Methyl-1-morpholinopropan-2-amine
CAS Number: 6105-75-5
Molecular Formula: C8H18N2O
Molecular Weight: 158.2413
MDL Number: MFCD01714129
SMILES: CC(CN1CCOCC1)(N)C
Properties
BP: 227.6°C at 760 mmHg  
Storage: Keep in dry area;2-8℃;  
Complexity: 119  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.4  
Downstream Synthesis Route
6105-75-5    121-60-8   
<i>N</i>-acetyl-sulfanilicacid-(morpholino-<i>tert</i>-butyl)-amide 

[1]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

110-91-8    2658-24-4    6105-75-5 

[1]CLAPP[JournaloftheAmericanChemicalSociety,1948,vol.70,#1,p.184-186]

33453-98-4    6105-75-5 

[1]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2017/17630,2017,A1Locationinpatent:Page/Pagecolumn33

[2]CurrentPatentAssignee:HAISCOPHARMACEUTICALGROUPCO.,LTD.-CN112480121,2021,ALocationinpatent:Paragraph1053;1057;1062-1066

[3]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

[4]Butler;McMillan[JournaloftheAmericanChemicalSociety,1950,vol.72,p.2978]

[5]Johnson[JournaloftheAmericanChemicalSociety,1946,vol.68,p.13]

[6]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-WO2006/18182,2006,A1Locationinpatent:Page/Pagecolumn68CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-WO2006/18185,2006,A2Locationinpatent:Page/Pagecolumn68

[7]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2006/35903,2006,A1Locationinpatent:Page/Pagecolumn18

[8]CurrentPatentAssignee:ONCOHEROESBIOSCIENCESINC-US2004/176380,2004,A1Locationinpatent:Page/Pagecolumn13

6105-75-5   
{5-(4-fluorobenzyl)-3-1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl-1H-pyrazol-1-yl}aceticacid 
 
N-(1,1-dimethyl-2-morpholin-4-ylethyl)-2-{5-(4-fluorobenzyl)-3-1-(4-methoxybenzyl)-1H-1,2,3-triazol-4-yl-1H-pyrazol-1-yl}acetamide 

[1]CurrentPatentAssignee:PFIZERINC-WO2008/4096,2008,A1Locationinpatent:Page/Pagecolumn84-85

Building Blocks More >
630424-76-9
630424-76-9
BOC-BETA-METHYL-DL-PHENYLALANINE
AA00E9YH | MFCD01823263
590360-21-7
590360-21-7
5-Chloro-2-[(2-fluorobenzyl)oxy]benzaldehyde
AA00EA2Q | MFCD03422425
60871-86-5
60871-86-5
3-(TRIETHOXYSILYLPROPYL)-P-NITROBENZAMIDE
AA00EAAT | MFCD00053612
59255-95-7
59255-95-7
2-Bromo-6-nitroaniline
AA00EAFF | MFCD09263476
6005-58-9
6005-58-9
2-Hydroxy-benzamide oxime
AA00EALJ | MFCD08061199
6241-30-1
6241-30-1
3-(4-Methylpiperidin-1-yl)propan-1-amine
AA00EARP | MFCD00129008
58386-20-2
58386-20-2
2,5-Dimethoxythiophene
AA00EAZ8 | MFCD01096545
56814-11-0
56814-11-0
2-Amino-n-cyclohexylbenzamide
AA00EB5T | MFCD00060339
65214-86-0
65214-86-0
4-Diphenylmethoxypiperidine, HCl
AA00EBC5 | MFCD16660392
64273-28-5
64273-28-5
5-Methyl-4-phenyl-1,2,3-thiadiazole
AA00EBIJ | MFCD00100201
Submit
© 2017 AA BLOCKS, INC. All rights reserved.